Mechanisms of synaptic pathology in Alzheimer's disease

Journal of Neural Transmission, Supplement

Volumn , Issue 53, 1998, Pages 147-158

  Masliah, E ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; HUMAN; NERVE DEGENERATION; PRIORITY JOURNAL; SYNAPSE; SYNAPTIC TRANSMISSION; BRAIN; BRAIN LEVEL; METABOLISM; PATHOLOGY; REVIEW;

AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; BRAIN; BRAIN CHEMISTRY; HUMANS; NERVE DEGENERATION; SYNAPSES;

EID: 0031596265     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6467-9_13     Document Type: Article

References (90)

1. Arai H, Lee VM-Y, Messinger ML, Greenberg BD, Lowery DE, Trojanowski JQ (1991) Expression patterns of β-amyloid precursor protein (β-APP) in neural and nenneural tissues from Alzheimer's disease and control subjects. Ann Neurol 30: 686-693
2. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT (1992a) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42: 631-639
3. Arriagada PV, Marzloff K, Hyman BT (1992b) Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 42: 1681-1688
4. Beach TG, Walker R, McGeer EG (1989) Patterns of gliosis in Alzheimer's disease and aging cerebrum. Glia 2: 420-436
5. Behl C, Davis J, Lesley R, Schubert D (1994) Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77: 817-827
6. Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, Prada CM, Kim G, Seekins S, Yager D (1996) Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ 1-42/1-40 ratio in vitro and in vivo. Neuron 17: 1005-1013
7. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239-259
8. Butterfield DA, Hensley K, Harris M, Mattson MP, Carney J (1994) β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem Biophys Res Commun 200: 710-715
9. Casado M, Bendahan A, Zafra F, Danbolt NC, Aragon C, Gimenez C, Kanner BI (1993) Phosphorylation and modulation of brain glutamate transporters by protein kinase C. J Biol Chem 268: 27313-27317
10. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Liberburg I, Selkoe DJ (1992) Mutation in the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 360: 672-674
11. Citron M, Westaway D, Xia W, Carlson G, Diehl T, Levesque G, Johnson-Wood K, Lee M, Subert P, Davis A, Kholodenko D, Motter R, Sherrington R, Perry B, Hong Y, Strome R, Lieberburg I, Rommens J, Kim S, Schenk D, Fraser P, St. George Hyslop P, Selkoe D (1997) Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nature Med 3: 67-72
12. Clark RF, Goate AM (1993) Molecular genetics of Alzheimer's disease. Arch Neurol 50: 1164-1172
13. Cole GM, Masliah E, Huynh TV, DeTeresa R, Terry RD, Okudea C, Saitoh T (1989) An antiserum against amyloid β-protein precursor detects a unique peptide in Alzheimer brain. Neurosci Lett 100: 340-346
14. Collaborative Group (1995) The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Alzheimer's Disease Collaborative Group. Nature Genet 11: 219-222
15. Cowburn R, Hardy J, Roberts P, Briggs R (1988) Presynaptic and postsynaptic glutamatergic function in Alzheimer's disease. Neurosci Lett 86: 109-113
16. Cowburn RF, Hardy JA, Roberts PJ (1990) Glutamatergic neurotransmission in Alzheimer's disease. Biochem Soc Trans 18: 390-392
17. Cras P, Kawai M, Lowery D, Gonzalez-DeWhitt P, Greenberg B, Perry G (1991) Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. Proc Natl Acad Sci USA 88: 7552-7556
18. Cummings BJ, Cotman CW (1995) Image analysis of β-amyloid load in Alzheimer's disease and relation to dementia severity. Lancet 346: 1524-1528
19. De Strooper B, Craessaerts K, Dewachter I, Moechars D, Greenberg B, Van Leuven F, Van Den Berghe H (1995) Missorting of amyloid precursor protein in MDCK cells. J Biol Chem 270: 4058-4065
20. DeKosky ST, Scheff SW (1990) Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 27: 457-464
21. Dickson DW, Farlo J, Davies P, Crystal H, Fuld P, Yen SC (1988) Alzheimer disease. A double immunohistochemical study of senile plaques. Am J Pathol 132: 86-101
22. Eccles JC (1981) The modular operation of the cerebral neocortex considered as the material basis of mental events. Neuroscience 6: 1839-1856
23. Eccles JC (1984) The cerebral neocortex: a theory of its operation. In: Jones EG, Peters A (eds) Cerebral cortex, vol 2. Functional properties of cortical cells. Plenum Press, New York, pp 1-38
24. Furukawa K, Sopher BL, Rydel RE, Begley JG, Pham DG, Martin GM, Fox M, Mattson MP (1996) Increased activity regulating and neuroprotective efficacy of α-secretase-derived secreted amyloid precursor protein conferred by a c-terminal heparin-binding domain. J Neurochem 67: 1882-1892
25. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemes J, Donaldson T, Gillespie F, Guido T, Hagopian S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Montoya-Zavala M, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373: 523-527
26. Games D, Masliah E, Lee M, Johnson-Wood K, Schenk D (1997) Neurodegenerative Alzheimer-like pathology in PDAPP 717V→F transgenic mice. In: Hyman BT, Duyckaerts C, Christen Y (eds) Connections, cognition and Alzheimer's disease. Springer, Berlin Heidelberg New York Tokyo, pp 105-119
27. Goate A, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, Fidani L, Guiffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Williamson R, Rossor M, Owen M, Hardy J (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349: 704-706
28. Golde TE, Estus S, Younkin LH, Selkoe DJ, Younkin SG (1992) Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science 255: 728-730
29. Gomez-Isla T, Price JL, McKeel DW Jr, Morris JC, Growdon JH, Hyman BT (1996) Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci 16: 4491-4500
30. Goodman Y, Mattson MP (1994) Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide-induced oxidative injury. Exp Neurol 128: 1-12
31. Haass C, Koo E, Capell A, Teplow D, Selkoe DJ (1995) Polarized sorting of β-amyloid precursor protein and its proteolytic products in MDCK cells is regulated by two independent signals. J Cell Biol 128: 537-547
32. Harris ME, Wang Y, Pedigo NWJr, Hensley K, Butterfield DA, Carney JM (1996) Amyloid β peptide (25-35) inhibits Na+-dependent glutamate uptake in rat hippocampal astrocyte cultures. J Neurochem 67: 277-286
33. Heinonen O, Soininen H, Sorvari H, Kosunene O, Paljarvi L, Koivisto E, Riekkinen PJ (1995) Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease. Neuroscience 64: 375-384
34. Hof PR, Morrison JH (1991) Neocortical neuronal subpopulations labeled by a monoclonal antibody to calbindin exhibit differential vulnerability in Alzheimer's disease. Exp Neurol 111: 293-301
35. Hof PR, Morrison JH (1994) The cellular basis of cortical disconnection in Alzheimer disease and related dementing conditions. In: Terry RD, Katzman R, Bick KL (eds) Alzheimer disease. Raven Press, New York, pp 197-230
36. Hyman BT, Van Hoesen GW, Kromer LJ, Damasio AR (1986) Perforant pathway changes in the memory impairment of Alzheimer's disease. Ann Neurol 20: 472-481
37. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara I (1994) Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species in A beta 42(43). Neuron 13: 45-53
38. Kovacs DM, Fausett HJ, Page KJ, Kim TW, Moir RD, Merriam DE, Hollister RD, Hallmark OG, Mancini R, Felsenstein KM (1996) Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nature Med 2: 224-229
39. Lassmann H, Weiler R, Fischer P, Bancher C, Jellinger K, Floor E, Danielczyk W, Seitelberger F, Winkler H (1992) Synaptic pathology in Alzheimer's disease: immunological data for markers of synaptic and large dense-core vesicles. Neuroscience 46: 1-8
40. Liu X, Erikson C, Brun A (1996) Cortical synaptic changes and gliosis in normal aging, Alzheimer's disease and frontal lobe degeneration. Dementia 7: 128-134
41. Lo A, Haass C, Wagner S, Teplow D, Sisodia S (1994) Metabolism of the "Swedish" amyloid precursor protein variant in Madin-Darby canine kidney cells. J Biol Chem 269: 30966-30973
42. Lorenzo A, Yankner BA (1994) β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc Natl Acad Sci USA 91: 12243-12247
43. Mark RJ, Hensley K, Butterfield DA, Mattson MP (1995) Amyloid β-peptide impairs ionmotive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death. J Neurosci 15: 6239-6249
44. Martin LJ, Cork LC, Koo EH, Sisodia SS, Weidemann A, Beyreuther K, Masters C, Price DL (1989) Localization of amyloid precursor protein (APP) in brains of young and aged monkeys. Soc Neurosci Abstr 15: 23
45. Martin LJ, Pardo CA, Cork LC, Price DL (1994) Synaptic pathology and glial reponses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. Am J Pathol 145: 1358-1381
46. Masliah E (1995) Mechanisms of synaptic dysfunction in Alzheimer's disease. Histol Histopathol 10: 509-519
47. Masliah E, Terry R (1994) The role of synaptic pathology in the mechanisms of dementia in Alzheimer's disease. Clin Neurosci 1: 192-198
48. Masliah E, Mallory M, Hansen L, Alford M, Albright T, Terry R, Shapiro P, Sundsmo M, Saitoh T (1991) Immunoreactivity of CD45, a protein phosphotyrosine phosphatase, in Alzheimer disease. Acta Neuropathol 83: 12-20
49. Masliah E, Mallory M, Ge N, Saitoh T (1992a) Amyloid precursor protein is localized in growing neuntes of neonatal rat brain. Brain Res 593: 323-328
50. Masliah E, Mallory M, Hansen L, Alford M, DeTeresa R, Terry R, Baudier J, Saitoh T (1992b) Localization of amyloid precursor protein in GAP43-immunoreactive aberrant sprouting neurites in Alzheimer's disease. Brain Res 574: 312-316
51. Masliah E, Mallory M, Hansen L, Alford M, DeTeresa R, Terry R (1993) An antibody against phosphorylated neurofilaments identifies a subset of damaged association axons in Alzheimer's disease. Am J Pathol 142: 871-882
52. Masliah E, Mallory M, Hansen L, DeTeresa R, Alford M, Terry R (1994) Synaptic and neuritic alterations during the progression of Alzheimer's disease. Neurosci Lett 174: 67-72
53. Masliah E, Alford M, DeTeresa R, Mallory M, Hansen L (1996a) Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann Neurol 40: 759-766
54. Masliah E, Sisk A, Mallory M, Mucke L, Schenk D, Games D (1996b) Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F β-amyloid precursor protein and Alzheimer's disease. J Neurosci 16: 5795-5811
55. Masliah E, Westland CE, Abraham CR, Mallory M, Veinbergs I, Rockenstein EM, Mucke L (1997) Amyloid precursor protein protects neurons of transgenic mice against acute and chronic excitotoxic injuries in vivo. Neuroscience 78: 135-141
56. Masters CL, Multhaup G, Simms G, Pottglesser J, Martins RN, Beyreuther K (1985) Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J 4: 2757-2763
57. Mattson MP, Cheng B, Culwell AR, Esch FS, Lieberburg I, Rydel RE (1993a) Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein. Neuron 10: 243-254
58. Mattson MP, Tomaselli KJ, Rydel RE (1993b) Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res 621: 35-49
59. Mucke L, Masliah E, Johnson WB, Ruppe MD, Rockenstein EM, Forss-Petter S, Pietropaolo M, Mallory M, Abraham CR (1994) Synaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic mice. Brain Res 666: 151-167
60. Mucke L, Abraham CR, Ruppe MD, Rockenstein EM, Toggas SM, Alford M, Masliah E (1995) Protection against HIV-1 gp 120-induced brain damage by neuronal overexpression of human amyloid precursor protein (hAPP). J Exp Med 181: 1551-1556
61. Pericak-Vance MA, Bass MP, Yamaoka LH, Gaskell PC, Scott WK, Terwedow HA, Menold MM, Conneally PM, Small GW, Vance JM, Saunders AM, Roses AD, Haines JL (1997) Complete genomic screen in late-onset familial Alzheimer disease. JAMA 278: 1237-1241
62. Perry EK, Perry RH, Blessed G, Tomlinson BE (1977) Neurotransmitter enzyme abnormalities in senile dementia: CAT and GAD activities in necropsy tissue. J Neurol Sci 34: 247-265
63. Perry EK, McKeith I, Thompson P (1991) Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease. Ann NY Acad Sci 640: 197-202
64. Price DL, Sisodia SS, Gandy SE (1995) Amyloid β amyloidosis in Alzheimer's disease. Curr Opin Neurol 8: 268-274
65. Rockenstein EM, McConlogue L, Tan H, Power M, Masliah E, Mucke L (1995) Levels and alternative splicing of amyloid β protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease. J Biol Chem 270: 28257-28267
66. Rogers J, Luber-Narod J, Styren SD, Civin WH (1988) Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease. Neurobiol Aging 9: 339-349
67. Rothstein JD, Jin L, Dykes-Hoberg M, Kuncl RW (1993) Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc Natl Acad Sci USA 90: 6591-6595
68. Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW (1995) Selective loss of glial glutamate trasporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 38: 73-84
69. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, Kanai Y, Hediger MA, Wang Y, Schielke JP (1996) Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16: 675-686
70. Saitoh T, Kang D, Mallory M, DeTeresa R, Masliah E (1997) Glial cells in Alzheimer's disease: preferential effect of APOE risk on scattered microglia. Gerontology 43: 109-118
71. Samuel W, Masliah E, Terry R (1994) Hippocampal connectivity and Alzheimer's dementia: effects of pathology in a two-component model. Neurology 44: 2081-2088
72. Saunders AM, Strittmatter WJ, Schmechel D, St. George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD (1993) Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467-1472
73. Scott HL, Tannenberg AEG, Dodd PR (1995) Variant forms of neuronal glutamate trasporter sites in Alzheimer's disease cerebral cortex. J Neurochem 64: 2193-2202
74. Selkoe DJ (1989) Amyloid β protein precursor and the pathogenesis of Alzheimer's disease. Cell 58: 611-612
75. Selkoe DJ (1993) Physiological production of the β-amyloid protein and the mechanisms of Alzheimer's disease. Trends Neurosci 16: 403-409
76. Selkoe D (1994a) Cell biology of the amyloid β-protein precursor and the mechanisms of Alzheimer's disease. Annu Rev Cell Biol 10: 373-403
77. Selkoe DJ (1994b) Normal and abnormal biology of the β-amyloid precursor protein. Ann Rev Neurosci 17: 489-517
78. Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Davis D, Sinha S, Schlossmacher M, Whaley J, Swindlehurst C, McCormack R, Wolfert R, Selkoe D, Lieberburg I, Schenk D (1992) Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359: 325-327
79. Shoji M, Golde TE, Ghiso J, Cheung TT, Estus S, Shaffer LM, Cai X-D, McKay DM, Tintner R, Frangione B, Younkin SG (1992) Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 258: 126-129
80. Sisodia SS, Price DL (1995) Role of the β-amyloid protein in Alzheimer's disease. FASEB J 9: 366-370
81. Sisodia SS, Koo EH, Beyreuther K, Unterbeck A, Price DL (1990) Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 248: 492-494
82. Terry RD, Wisniewski HM (1970) The ultrastructure of the neurofibrillary tangle and the senile plaque. In: Wolstenholme GEW, O'Connor M (eds) Ciba Foundation Symposium on Alzheimer's disease and related conditions. Churchill, London, pp 145-168
83. Terry RD, Peck A, DeTeresa R, Schechter R, Horoupian DS (1981) Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol 10: 184-192
84. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30: 572-580
85. Terry RD, Hansen L, Masliah E (1994) Structural alterations in Alzheimer disease. In: Terry RD, Katzman R (eds) Alzheimer disease. Raven Press, New York, pp 179-196
86. Voytko ML, Olton DS, Richardson RT, Gorman LK, Tobin JR, Price DL (1994) Basal forebrain lesions in monkeys disrupt attention but not learning and memory. J Neurosci 14: 167-186
87. 2+ channel blockers attenuate β-amyloid peptide toxicity to cortical neurons in culture. J Neurochem 62: 372-375
88. Wragg M, Hutton M, Talbot C, Alzheimer's Disease Collaborative Group (1996) Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Lancet 347: 509-512
89. Yamaguchi H, Hirai S, Morimatso M, Shoji M, Ihara Y (1988) A variety of cerebral amyloid deposits in the brains of Alzheimer-type dementia demonstrated by β-protein immunostaining. Acta Neuropathol 76: 541-549
90. Yankner BA (1996) Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16: 921-932